Bosch Health Campus Logo Bosch Health Campus Logo
Home
Team
Jana Koch
Scientist

Dr. Jana Koch


Tel +49-711-8101 5644

Major Projects

  • Biomarkerstudies
  • Tumorvirology
  • Combination therapies (target therapy, oncolytic viruses)

Selected References

Jana Koch, Julia Beil, Susanne Berchtold, Dina Mönch, Annika Maaß, Irina Smirnow, Andrea Schenk, Mary E. Carter, Linus D. Kloker, Tobias Leibold, Philipp Renner, Marc-H. Dahlke, Ulrich M. Lauer, „Establishing a new platform to investigate the efficacy of oncolytic virotherapy in a human ex vivo peritoneal carcinomatosis model”, Viruses , 2023; 15, 363
Jana Koch, Dina Mönch, Annika Maaß, Alina Mangold, Miodrag Guzvic, Thomas Mürdter, Tobias Leibold, Marc-H. Dahlke, Philipp Renner, „Pharmacologic targeting of MMP2/9 decreases peritoneal metastasis formation of colorectal cancer in a human ex vivo peritoneum culture model“, Cancers (Basel) , 2022; 14(15), 3760
Jana Koch, Sebastian Schober, Sruthi Hindupur*, Caroline Schöning, Florian Klein, Klaus Mantwill, Maximilian Ehrenfeld, Ulrike Schillinger, Timmy Hohnecker, Qi Pan, Katja Steiger, Michaela Aichler, Jürgen Gschwend, Per Sonne Holm, Roman Nawroth, „Targeting the RB/E2F repressive complex by CDK4/6 inhibitors amplifies the oncolytic potency of XVir-N-31“, Nat Commun , 2022; 13, 4689
Dina Mönch, Jana Koch, Annika Maaß, Nicole Janssen, Thomas Mürdter, Philipp Renner, Petra Fallier-Becker, Wiebke Solaß, Matthias Schwab, Marc-H. Dahlke, Hans J. Schlitt, Tobias Leibold, “A human ex vivo co-culture model to investigate peritoneal metastasis and innovative treatment options”, Pleura Peritoneum
Jana Koch, Dina Mönch, Annika Maaß, Christian Gromoll, Thomas Hehr, Tobias Leibold, Hans J. Schlitt, Marc-H. Dahlke, Philipp Renner, “Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines“, PLoS ONE , 2021; 16(1), e0244513

Curriculum Vitae

Education and Professional Career

Since 09/2018

Scientist at the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

2015-2018

PhD Thesis at the Institute of Molecular Uro-Oncology, Klinikum Rechts der Isar der TU Munich, ’Combining Oncolytic Virotherapy with Target Therapy in Bladder Cancer’

2014/2015

Masterthesis at the Institut of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; ‘Studies on Human Papillomavirus and p16INK4a Overexpression in Hypopharyngeal Cancer’

2010-2015

Study of Molecular Medicine, Ulm University